Invivyd reported Q4 2024 revenue of $13.8 million, highlighting significant growth and ongoing development of COVID-19 treatments PEMGARDA and VYD2311. Invivyd, Inc. reported a net product revenue ...

WALTHAM, Mass., March 26, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) is pleased to announce the appointment of Ajay Royan to its Board of Directors. Mr. Royan is a venture capitalist ...

PEMGARDA™ (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue of $9.3 million; full-year 2024 net product revenue totaled $25.4 million2024 year ...

In this article, we are going to take a look at where Invivyd, Inc. (NASDAQ:IVVD) stands against the other biotech stocks. No ...

In this article, we are going to take a look at where Invivyd, Inc. (NASDAQ:IVVD) stands against other best penny stocks to buy according to the media. On December 24, Global Advisors’ managing ...

2; affirms structural biology within Invivyd’s unique technology and reflects consistently stable epitope for pemivibart VYD2311 also demonstrates stable epitope and clinically meaningful in ...

Invivyd (IVVD) announced positive, continued, clinically meaningful in vitro neutralization data for PEMGARDA against the currently dominant LP.8.1 variant of SARS-CoV-2. Notably, and consistent ...

Invivyd has a 1-year low of $0.35 and a 1-year high of $4.74. Insiders Place Their Bets In other Invivyd news, Director Terrance Mcguire sold 150,000 shares of Invivyd stock in a transaction that ...

Invivyd has a fifty-two week low of $0.35 and a fifty-two week high of $4.74. Invivyd ( NASDAQ:IVVD – Get Free Report ) last issued its quarterly earnings data on Thursday, March 20th.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The latest analyst rating for Invivyd (NASDAQ:IVVD) was provided by HC Wainwright & Co., and Invivyd reiterated their buy rating. The last upgrade for Invivyd Inc happened on April 5, 2024 when ...

March 20, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced financial ...